GNCA Genocea Biosciences Inc.

5.29
+0.00  (0%)
Previous Close 5.29
Open 5.28
Price To book 7.90
Market Cap 151680567
Shares 28,673,075
Volume 119,014
Short Ratio 14.58
Av. Daily Volume 569,657

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171017914
  2. 8-K - Current report 171016492
  3. 8-K - Current report 17977524
  4. 8-K - Current report 17913558
  5. CT ORDER - Confidential treatment order 17883756

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Topline data did not meet endpoints - September 2015
GEN-004
Universal vaccine candidate against pneumococcus
Phase 2b data released January 6, 2017. 12-month data released July 24, 2017. Phase 3 to commence 4Q 2017.
GEN-003
Genital herpes

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171017914
  2. 8-K - Current report 171016492
  3. 8-K - Current report 17977524
  4. 8-K - Current report 17913558
  5. CT ORDER - Confidential treatment order 17883756
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 17817013
  7. 8-K - Current report 17811910
  8. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 17774382
  9. DEF 14A - Other definitive proxy statements 17774335
  10. 8-K - Current report 17765349